InnovAge Holding Corp. (NASDAQ: INNV)

Sector: Healthcare Industry: Medical Care Facilities CIK: 0001834376
Market Cap 810.37 Mn
P/B 3.31
P/E -46.67
P/S 0.92
ROIC (Qtr) -4.74
Div Yield % 0.00
Rev 1y % (Qtr) 15.09
Total Debt (Qtr) 98.08 Mn
Debt/Equity (Qtr) 0.40

About

InnovAge Holding Corp., or INNV, is a leading healthcare delivery platform operating within the healthcare industry. The company primarily focuses on providing comprehensive, capitated care to high-cost seniors, many of whom are dual-eligible. InnovAge's unique approach emphasizes improving the quality of care while reducing costs, making it an attractive option for government payors and individuals alike. InnovAge's main business activities revolve around its Program of All-Inclusive Care for the Elderly (PACE), which serves the frail elderly...

Read more

Price action

Investment thesis

Bull case

  • Strong operating cash flow of 44.31M provides robust 0.45x coverage of total debt 98.08M, indicating excellent debt servicing capability and financial flexibility.
  • Healthy cash reserves of 67.16M provide 5.25x coverage of short-term debt 12.80M, demonstrating strong liquidity position and minimal refinancing risk.
  • Strong tangible asset base of 364.48M provides 3.72x coverage of total debt 98.08M, indicating robust asset backing and low credit risk.
  • Operating cash flow of 44.31M provides exceptional 10.90x coverage of interest expenses 4.06M, showing strong debt service capability.
  • Robust free cash flow of 36.17M exceeds capital expenditure of 8.14M by 4.44x, indicating strong organic growth funding capability.

Bear case

  • Operating cash flow of 44.31M barely covers its investment activities of (3.57M), with a coverage ratio of -12.40, indicating heavy reliance on external financing for growth which may not be sustainable in a tighter credit environment.
  • Cash reserves of 67.16M provide limited coverage of acquisition spending of (1.06M), which is -63.48x, suggesting aggressive expansion might strain liquidity if market conditions deteriorate.
  • Operating earnings of (12.14M) show weak coverage of depreciation charges of 19.18M, with a -0.63 ratio indicating high capital intensity and potential reinvestment needs.
  • High depreciation of 19.18M relative to operating cash flow of 44.31M, which is 0.43x suggests significant maintenance capital requirements affecting free cash flow.
  • Free cash flow of 36.17M represents just -3.95x of debt issuance (9.16M), suggesting concerning reliance on leverage rather than internal cash generation for growth.

Peer comparison

Companies in the Medical Care Facilities
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 HCA HCA Healthcare, Inc. 114.88 Bn 18.11 1.54 46.35 Bn
2 THC Tenet Healthcare Corp 18.07 Bn 13.34 0.87 13.19 Bn
3 UHS Universal Health Services Inc 14.64 Bn 10.65 0.86 5.11 Bn
4 FMS Fresenius Medical Care AG 14.10 Bn 16.69 0.61 14.98 Bn
5 EHC Encompass Health Corp 12.55 Bn 19.95 2.17 2.66 Bn
6 ENSG Ensign Group, Inc 10.08 Bn 30.72 2.09 2.16 Bn
7 DVA Davita Inc. 8.90 Bn 11.53 0.67 12.78 Bn
8 CHE Chemed Corp 6.38 Bn 22.87 2.52 0.14 Bn

Industry comparisons

Current Valuation Value Ind Avg Percentile
EV to Assets EV to Assets 1.69 1.26
EV to Cash from Ops. EV/CFO 19.48 12.78
EV to Debt EV to Debt 8.80 12.10
EV to EBIT EV/EBIT -71.10 10.74
EV to EBITDA EV/EBITDA 330.74 16.04
EV to Free Cash Flow [EV/FCF] EV/FCF 23.87 18.02
EV to Market Cap EV to Market Cap 1.04 432.64
EV to Revenue EV/Rev 0.98 2.77
Price to Book Value [P/B] P/B 3.37 -1.92
Price to Earnings [P/E] P/E -47.58 5.13
Dividend Metrics Value Ind Avg Percentile
Dividend Coverage Ratio Dividend Coverage Ratio 0.00 0.10
Dividend Payout Ratio % Div Payout % (Qtr) 0.00 -13.44
Dividend per Basic Share Div per Share (Qtr) 0.00 0.27
FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) 0.00 5.42
Interest Coverage Int. cover (Qtr) -2.99 -97.94
Growth Metrics Value Ind Avg Percentile
Capex Growth (1y) % Capex 1y % (Qtr) -7.91 -114.65
Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) 72.06 65.22
Dividend Growth (1y) % Dividend Growth (1y) % 0.00 0.97
EBIAT Growth (1y) % EBIAT 1y % (Qtr) -19.88 -46.98
EBITDA Growth (1y) % EBITDA 1y % (Qtr) -4.54 75.97
EBIT Growth (1y) % EBIT 1y % (Qtr) -24.17 -61.19
EBT Growth (1y) % EBT 1y % (Qtr) -12.68 -115.48
EPS Growth (1y) % EPS 1y % (Qtr) 7.69 -24.32
FCF Growth (1y) % FCF 1y % (Qtr) 290.63 309.51
Gross Profit Growth (1y) % Gross Profit 1y % (Qtr) 22.87 17.88
Liquidity Ratios Value Ind Avg Percentile
Asset Utilization Ratio Asset Util Ratio (Qtr) 1.73 1.04
Cash Payout Ratio Cash Payout (Qtr) 0.00 0.04
Cash Ratio Cash Ratio (Qtr) 0.48 0.39
Current Ratio Curr Ratio (Qtr) 1.17 1.39
Debt to Equity Ratio Debt/Equity (Qtr) 0.40 -13.19
Interest Cover Ratio Int Coverage (Qtr) -2.99 -97.94
Times Interest Earned Times Interest Earned (Qtr) -2.99 -97.94
Profitability Value Ind Avg Percentile
EBITDA Margin % EBITDA Margin % (Qtr) 0.80 -95.81
EBIT Margin % EBIT Margin % (Qtr) -1.37 -94.97
EBT Margin % EBT Margin % (Qtr) -1.83 -105.60
Gross Margin % Gross Margin % (Qtr) 19.30 23.31
Net Profit Margin % Net Margin % (Qtr) -2.00 -106.14